Korsana Biosciences
KRSA
31.65
-0.12
-0.38%
Korsana Biosciences
US · KRSA
#2830 by market cap
Listed 1970
31.65
-0.12
-0.38%
Live - 5344 symbols - heartbeat 437s ago
· 2026-10-08 02:52
After-hours
31.30
-1.11%
Overnight
31.65
0.00%
- Market cap
- 1.97B
- P/E (TTM)i
- -45.21
- P/Bi
- 4.40
- EPSi
- -0.70
- Div yieldi
- 0.00%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on KRSA?
Anonymous reader poll. Unscientific, not investment advice.
About Korsana Biosciences
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
- Founded
- 2018
- CEO
- Dr. Jonathan Violin, M.B.A.,PhD
- Employees
- 19
- Headquarters
- Cambridge, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- cyclerion.com
Company profile
- Exchange
- US
- Symbol
- KRSA
- Market-cap rank
- #2830
- Listing date
- 1970-01-01
- Market cap
- 1.97B
- Float cap
- 1.57B
- Shares out
- 62.36M
- Float shares
- 49.57M
Sectors & themes
Quote time 2026-10-08 02:52:54 · For reference only, not investment advice and not tailored to your situation.